Skip to main content
  • 114 Accesses

Synonyms

Adenylyl cyclase (preferred); Adenylate cyclase; Adenyl cyclase (original); ATP:pyrophosphate lyase; Cyclizing (E.C.4.6.1.1.)

Definition

Adenosine 3′:5′‐monophosphate (cAMP) regulates effects in all eukaryotic cells, principally through activation of cAMP‐dependent protein kinase (PKA), but also through cAMP‐gated ion channels (CNGs) and select guanine nucleotide exchange factors (Epacs) (Fig. 1). Cellular levels of cAMP levels reflect the balance of activities of adenylyl cyclases (AdCy: 5′‐ATP ⎨ cAMP + PPi) and cAMP phosphodiesterases (PDE: cAMP ⎨ 5′‐AMP). Adenylyl cyclases occur throughout the animal kingdom and play diverse roles in cell regulation [1].

Adenylyl Cyclases. Figure 1
figure 1_3

Synthesis, degradation, and actions of cAMP.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 849.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 999.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

Ado:

adenosine

cAMP:

adenosine‐3′:5′ monophosphate

2′‐d‐Ado:

2′‐deoxyadenosine

2′‐d‐2‐F‐Ado:

2′‐deoxy‐2‐fluoro‐adenosine

3′‐d‐Ado:

3′‐deoxyadenosine (cordycepin)

2′,5′‐dd‐Ado:

2′,5′‐dideoxyadenosine

2′,3′‐dd‐Ado:

2′,3′‐dideoxyadenosine

2′,5′‐dd‐2‐F‐Ado:

2′,5′‐dideoxy‐2‐fluoro‐adenosine

2′,5′‐dd‐2,5′‐di‐F‐Ado:

2′,5′‐dideoxy‐5′‐fluoro‐2‐fluoro‐adenosine

9‐CP‐Ade:

9‐(cyclopentyl)‐adenine

9‐THF‐Ade:

9‐(tetrahydrofuryl)‐adenine (SQ22,536)

9‐Ara‐Ade:

9‐(arabinofuranosyl)‐adenine

9‐Xyl‐Ade:

9‐(xylofuranosyl)‐adenine

2′‐d‐Xyl‐Ade:

9‐(2‐deoxyxylosyl)‐adenine

2′,5′‐dd‐Xyl‐Ade:

9‐(2,5‐dideoxyxylosyl)‐adenine

2′‐d‐3′‐AMP:

2′‐deoxyadenosine‐3′‐monophosphate

2′‐d‐3′‐ADP:

2′‐deoxyadenosine‐3′‐diphosphate

2′‐d‐3′‐ATP:

2′‐deoxyadenosine‐3′‐triphosphate

2′‐d‐3′‐AMPS:

3′‐(thiophosphoryl)‐2′‐deoxyadenosine

2′,5′‐dd‐3′‐AMP:

2′,5′‐dideoxyadenosine‐3′‐monophosphate

2′,5′‐dd‐3′‐ADP:

2′,5′‐dideoxyadenosine‐phos‐phate‐3′‐diphosphate

2′,5′‐dd‐3′‐ATP:

2′,5′‐dideoxyadenosine‐3′‐triphosphate

2′,5′‐dd‐3′‐A4P:

2′,5′‐dideoxyadenosine‐phos‐phate‐3′‐tetraphosphate

2′,5′‐dd‐3′‐AMPS:

3′‐(thiophosphoryl)‐2′,5′‐dideoxyadenosine

5′‐APP(CH2)P:

adenosine 5′‐(β(‐methylene)‐triphosphate

β‐L‐5′‐ATP:

β‐L‐adenosine‐5′‐triphosphate

β‐L‐2′,3′‐dd‐5′‐ATP:

β‐L‐2′,3′‐dideoxyadenosine‐5′‐triphosphate

PMEA:

9‐[(2‐phosphonylmethoxy(ethyl)]‐adenine

PMEApp:

9‐[(2‐diphosphorylphosphonylmethoxy(ethyl)]‐adenine

PMEAp(NH)p:

9‐[(2‐iminodiphosphorylphosphonylmethoxy(ethyl)]‐adenine

PMPA:

9‐[(2‐phosphonylmethoxy)propyl]‐adenine

PMPApp:

9‐[(2‐diphosphorylphosphonylmethoxy(propyl)]‐adenine

2′,5′‐dd‐3′‐AMP‐bis(Me‐SATE):

2′,5′‐dideoxyadenosine‐3′‐(acetyl‐2‐thioethyl)‐phosphate

2′,5′‐dd‐3′‐AMP‐bis(t‐Bu‐SATE):

2′,5′‐dideoxyadenosine‐3′‐(pivaloyl‐2‐thioethyl)‐phosphate

2′,5′‐dd‐3′‐AMP‐bis(Ph‐SATE):

2′,5′‐dideoxyadenosine‐3′‐(phenyl‐2‐thioethyl)‐phosphate

2′,5′‐dd‐2F‐Ado‐3′‐P‐bis(Me‐SATE):

2′,5′‐dd‐2‐fluoro‐adenosine‐3′‐(acetyl‐2‐thioethyl)‐phosphate

MANT‐5′‐GTPγS:

3′‐(2′)‐O‐N‐methylanthraniloyl‐guanosine‐5′‐[γ‐thio]triphosphate

MANT‐5′‐ITPγS:

3′‐(2′)‐O‐N‐methylanthraniloyl‐inosine‐5′[γ‐thio]triphosphate

MANT‐5′ATP:

3′‐(2′)‐O‐N‐methylanthraniloyl‐5′‐ATP

MANT‐5′GTP:

3′‐(2′)‐O‐N‐methylanthraniloyl‐5′‐GTP

3′‐MANT‐2′‐d‐5′‐ATP:

3′‐O‐N‐methylanthraniloyl‐2′‐deoxy‐5′‐ATP

3′‐7M4AMC‐2′‐d‐5′‐ATP:

3′‐(7‐methoxy‐4‐aminomethylcoumarinn)‐2′‐deoxy‐5′‐ATP

3′‐Dansyl‐2′‐d‐5′‐ATP:

3′‐(dansyl)‐2′‐deoxy‐5′‐ATP

2′,5′‐dd‐3′‐ADP‐(β‐7M4AMC):

2′,5′‐dideoxyadenosine‐{β‐(7‐methoxy‐4‐aminomethyl‐coumarin)}‐3′‐diphosphate

2′,5′‐dd‐3′‐ATP‐(γ‐7M4AMC):

2′,5′‐dideoxyadenosine‐{γ‐(7‐methoxy‐4‐aminomethyl‐coumarin)}‐3′‐triphosphate

2′,5′‐dd‐3′‐ATP‐(γ‐7A4AMC):

2′,5′‐dideoxyadenosine‐{γ‐(7‐amino‐4‐aminomethyl‐coumarin)}‐3′‐triphosphate

References

  1. Hanoune J, Defer N (2001) Regulation and role of adenylyl cyclase isoforms. Annu Rev Pharmacol Toxicol 41:145–174

    Article  PubMed  CAS  Google Scholar 

  2. Linder JU, Schultz JE (2003) The Class III adenylyl cyclases: multi‐purpose signalling modules. Cell Signal 15:1081–1089

    Article  PubMed  CAS  Google Scholar 

  3. Tesmer JJG, Sunahara RK, Johnson RA et al (1999) Two‐metal‐ion catalysis in adenylyl cyclase. Science 285:756–760

    Article  PubMed  CAS  Google Scholar 

  4. Shoshani I, Boudou V, Pierra C et al (1999) Enzymatic synthesis of unlabeled and [β‐32P]‐labeled β‐L‐2′,3′‐dideoxyadenosine‐5′‐triphosphate as a potent inhibitor of adenylyl cyclases and its use as reversible binding ligand. J Biol Chem 274:34735–34741

    Article  PubMed  CAS  Google Scholar 

  5. Désaubry L, Shoshani I, Johnson RA (1996) Inhibition of adenylyl cyclase by a family of newly synthesized adenine nucleoside 3′‐polyphosphates. J Biol Chem 271:14028–14034

    Article  PubMed  Google Scholar 

  6. Gille A, Seifert R (2003) 2′(3′)‐O‐(N‐methylanthraniloyl)‐substituted GTP analogs: a novel class of potent competitive adenylyl cyclase inhibitors. J Biol Chem 278:12672–12679

    Article  PubMed  CAS  Google Scholar 

  7. Laux WHG, Pande P, Shoshani I et al (2004) Pro‐nucleotide inhibitors of adenylyl cyclases in intact cells. J Biol Chem 279:13317–13332

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg New York

About this entry

Cite this entry

Johnson, R.A. (2008). Adenylyl Cyclases. In: Offermanns, S., Rosenthal, W. (eds) Encyclopedia of Molecular Pharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-38918-7_3

Download citation

Publish with us

Policies and ethics